<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27259">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02751866</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1256</org_study_id>
    <nct_id>NCT02751866</nct_id>
  </id_info>
  <brief_title>Early Intervention in Cognitive Aging</brief_title>
  <official_title>Early Intervention in Cognitive Aging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nutritional intervention in overweight middle aged individuals with subjective memory
      complaints.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Late-onset AD develops over many years during a preclinical period in which
      neuropathological changes accumulate before dementia is evident. Deposition of amyloid-beta
      (Aβ) in the brain is the earliest recognized biomarker of AD pathology, and,
      demographically, Aβ accumulation begins to accelerate at age 50, a period when the incidence
      of metabolic disturbance increases as well. Hyperinsulinemia associated with insulin
      receptor resistance has been associated with AD pathololgy, and metabolic disturbance in
      mid-life increases risk for subsequent dementia. There are indications that subjective
      memory complaints can be an early indicator of developing neuropathology and may be the
      first manifestation of future dementia. This research involve intervention studies in
      different samples of individuals from this population to investigate the extent to which
      berry fruit supplementation and ketone metabolism might improve memory performance in
      association with enhancement of metabolic function and related factors. The ultimate goal of
      this research is to develop interventional approaches that might be applied with at-risk
      individuals in the preclinical period of dementia to forestall or prevent progression of
      neurocognitive decline.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>Eight or 12 weeks after enrollment</time_frame>
    <description>HOMA-IR will be derived from fasting glucose and insulin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>Eight or 12 weeks after enrollment</time_frame>
    <description>Performances on examiner-adminstered instruments assessing memory function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long term glucose concentration</measure>
    <time_frame>Eight or 12 weeks after enrollment</time_frame>
    <description>Glycated hemoglobin value</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Overweight, Obesity and Other Hyperalimentation (E65-E68)</condition>
  <arm_group>
    <arm_group_label>Active berry fruit supplement; low carbohydrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Either blueberry powder or strawberry powder daily supplementation OR low carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo OR Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo powder OR higher carbohydrate diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Either berry fruit supplement OR nutritional ketosis</intervention_name>
    <description>Either supplementation with flavonoid-containing berry fruit OR carbohydrate-restricted diet designed to induce ketone metabolism</description>
    <arm_group_label>Active berry fruit supplement; low carbohydrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo powder OR higher carbohydrate diet</intervention_name>
    <arm_group_label>Placebo OR Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  overweight; subjective memory complaints

        Exclusion Criteria:

          -  diabetes; liver or kidney disease; age-related memory disorder; neurologic or
             psychiatric condition; substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Krikorian, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati Academic Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcelle D Shidler, MA</last_name>
    <phone>5135582455</phone>
    <email>marcelle.shidler@uc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept of Psychiatry &amp; Behavioral Neuroscience, UC Academic Health Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267-0559</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelle Shidler, MA</last_name>
      <phone>513-558-2455</phone>
      <email>marcelle.shidler@uc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 25, 2016</lastchanged_date>
  <firstreceived_date>April 21, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Robert Krikorian</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
